Publications by authors named "David P Boyle"

Claim this Profile
W
What factors influence cellular pathologists' confidence in case reporting?
Harriet Evans, Peter K Kimani, Louise Hiller, Yee Wah Tsang, Shatrughan Sah, David P Boyle

Virchows Arch· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.
Ayesha S Azam, Yee-Wah Tsang, Jenny Thirlwall, Peter K Kimani, Shatrughan Sah, David P Boyle

Histopathology· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
Peter Bankhead, José A Fernández, Darragh G McArt, David P Boyle, Gerald Li

Lab Invest· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment.
Niamh E Buckley, Claire Forde, Darragh G McArt, David P Boyle, Paul B Mullan

Sci Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated tumor analysis for molecular profiling in lung cancer.
Peter W Hamilton, Yinhai Wang, Clinton Boyd, Jacqueline A James, Maurice B Loughrey, David P Boyle

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PICan: An integromics framework for dynamic cancer biomarker discovery.
Darragh G McArt, Jaine K Blayney, David P Boyle, Gareth W Irwin, Michael Moran

Mol Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratified mucin-producing intraepithelial lesion (SMILE): report of a case series with associated pathological findings.
David P Boyle, W Glenn McCluggage

Histopathology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer.
David P Boyle, Darragh G McArt, Gareth Irwin, Charlotte S Wilhelm-Benartzi, Tong F Lioe

Histopathology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinicopathological markers of prognosis in breast cancer.
David P Boyle, Clare M McCourt, Kyle B Matchett, Manuel Salto-Tellez

Expert Rev Mol Diagn· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mapping the presence of druggable targets in preinvasive and precursor breast lesions: a comprehensive review of biomarkers related to therapeutic interventions.
David P Boyle, Paul Mullan, Manuel Salto-Tellez

Biochim Biophys Acta· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudoinvasion of benign squamous epithelium following cervical biopsy: a pseudoneoplastic phenomenon mimicking invasive squamous carcinoma.
David P Boyle, W Glenn McCluggage

J Clin Pathol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis